WallStSmart
GERN

Geron Corporation

NASDAQ: GERN · HEALTHCARE · BIOTECHNOLOGY

$1.54
+1.99% today

Updated 2026-04-30

Market cap
$980.58M
P/E ratio
P/S ratio
5.33x
EPS (TTM)
$-0.13
Dividend yield
52W range
$1 – $2
Volume
19.1M

Geron Corporation (GERN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-26.38M$-26.63M$-41.98M$-43.37M$-44.29M$-62.39M$-55.15M$-36.68M$9.35M$-24.20M$-18.37M$-20.56M$-21.01M$-43.83M$-66.65M$-95.56M$-127.38M$-167.74M$-218.62M$-111.04M
Capital expenditures$779000.00$2.99M$2.34M$1.44M$836000.00$612000.00$862000.00$3000.00$131000.00$90000.00$57000.00$16000.00$16000.00$413000.00$401000.00$207000.00$431000.00$830000.00$680000.00$49000.00
Depreciation
Stock-based comp$4.37M$11.49M$10.57M$13.72M$15.25M$5.31M$4.43M$7.66M$8.40M$8.24M$8.14M$6.37M$6.08M$6.89M$8.08M$8.00M$19.35M$31.32M$88000.00
Free cash flow$-27.16M$-29.62M$-44.32M$-44.81M$-45.13M$-63.00M$-56.01M$-36.68M$9.22M$-24.29M$-18.43M$-20.57M$-21.02M$-44.24M$-67.05M$-95.76M$-127.81M$-168.57M$-219.30M$-111.09M
Investing cash flow
Financing cash flow
Dividends paid$9.08M$6000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-29.87M$5.96M$-9.07M$29.81M$-21.55M$-8.44M$3.52M$-5.76M$3.07M$-3.63M$24.95M$21.95M